A Phase I Study of GSK2816126, an Enhancer of Zeste Homolog 2(EZH2) Inhibitor, in Patients (pts) with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Other Non-Hodgkin Lymphomas (NHL), Transformed Follicular Lymphoma (tFL), Solid Tumors and Multiple Myeloma (MM)
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Timothy A. Yap, Jane N. Winter, John P. Leonard, Vincent Ribrag, Anastasia Constantinidou, Lisa Giulino-Roth, Jean-Marie Michot, Tariq A Khan, Thierry Horner, Jennifer Carver, Teodora Pene Dumetrescu, Zangdong He, Michael T. McCabe, Caretha L. Creasy, Arindam Dhar, Christopher Carpenter, Peter M Johnson
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2591628145